Cigna Corporation Financial Statements (CI)
|
|
|
|
Report date
|
|
|
31.12.2023 |
29.02.2024 |
02.05.2024 |
01.08.2024 |
31.10.2024 |
|
31.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
51 114 |
51 080 |
55 419 |
60 475 |
63 694 |
|
230 668 |
|
Operating Income, bln rub |
|
|
1 029 |
1 029 |
2 256 |
2 412 |
1 732 |
|
7 429 |
|
EBITDA, bln rub |
? |
|
1 029 |
1 313 |
1 142 |
3 102 |
2 218 |
|
7 775 |
|
Net profit, bln rub |
? |
|
1 029 |
1 029 |
-277.0 |
1 548 |
86.0 |
|
2 386 |
|
|
OCF, bln rub |
? |
|
0.000 |
1 467 |
4 840 |
265.0 |
46.0 |
|
6 618 |
|
CAPEX, bln rub |
? |
|
0.000 |
365.0 |
300.0 |
370.0 |
399.0 |
|
1 434 |
|
FCF, bln rub |
? |
|
0.000 |
1 102 |
4 540 |
-105.0 |
-353.0 |
|
5 184 |
|
Dividend payout, bln rub
|
|
|
0.000 |
358.0 |
401.0 |
392.0 |
390.0 |
|
1 541 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
34.8% |
0.00% |
25.3% |
453.5% |
|
64.6% |
|
|
OPEX, bln rub |
|
|
50 085 |
39 497 |
45 522 |
48 533 |
3 590 |
|
137 142 |
|
Cost of production, bln rub |
|
|
0.000 |
9 280 |
9 440 |
9 515 |
9 527 |
|
37 762 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
0.000 |
360.0 |
322.0 |
375.0 |
376.0 |
|
1 433 |
|
|
Assets, bln rub |
|
|
0.000 |
147 926 |
148 447 |
150 851 |
157 639 |
|
157 639 |
|
Net Assets, bln rub |
? |
|
46 223 |
46 223 |
41 181 |
41 332 |
42 095 |
|
42 095 |
|
Debt, bln rub |
|
|
0.000 |
31 480 |
32 768 |
31 892 |
32 802 |
|
32 802 |
|
Cash, bln rub |
|
|
0.000 |
8 747 |
9 547 |
7 856 |
5 888 |
|
5 888 |
|
Net debt, bln rub |
|
|
0.00 |
22 733 |
23 221 |
24 036 |
26 914 |
|
26 914 |
|
|
Ordinary share price, rub |
|
|
299.5 |
299.5 |
363.2 |
330.6 |
346.4 |
|
318.9 |
|
Number of ordinary shares, mln |
|
|
294.6 |
292.5 |
286.5 |
281.1 |
278.5 |
|
278.5 |
|
|
Market cap, bln rub |
|
|
88 207 |
87 590 |
104 041 |
92 934 |
96 469 |
|
88 800 |
|
EV, bln rub |
? |
|
88 207 |
110 323 |
127 262 |
116 970 |
123 383 |
|
115 714 |
|
Book value, bln rub |
|
|
46 223 |
-28 899 |
-33 568 |
-33 102 |
-32 070 |
|
-32 070 |
|
|
EPS, rub |
? |
|
3.49 |
3.52 |
-0.97 |
5.51 |
0.31 |
|
8.57 |
|
FCF/share, rub |
|
|
0.00 |
3.77 |
15.8 |
-0.37 |
-1.27 |
|
18.6 |
|
BV/share, rub |
|
|
156.9 |
-98.8 |
-117.2 |
-117.7 |
-115.2 |
|
-115.2 |
|
|
EBITDA margin, % |
? |
|
2.01% |
2.57% |
2.06% |
5.13% |
3.48% |
|
3.37% |
|
Net margin, % |
? |
|
2.01% |
2.01% |
-0.50% |
2.56% |
0.14% |
|
1.03% |
|
FCF yield, % |
? |
|
10.4% |
11.7% |
9.77% |
8.57% |
5.37% |
|
5.84% |
|
ROE, % |
? |
|
8.21% |
8.21% |
5.47% |
5.66% |
5.67% |
|
5.67% |
|
ROA, % |
? |
|
|
2.57% |
1.52% |
1.55% |
1.51% |
|
1.51% |
|
|
P/E |
? |
|
23.2 |
23.1 |
46.2 |
39.7 |
40.4 |
|
37.2 |
|
P/FCF |
|
|
9.65 |
8.55 |
10.2 |
11.7 |
18.6 |
|
17.1 |
|
P/S |
? |
|
0.45 |
0.45 |
0.51 |
0.43 |
0.42 |
|
0.38 |
|
P/BV |
? |
|
1.91 |
-3.03 |
-3.10 |
-2.81 |
-3.01 |
|
-2.77 |
|
EV/EBITDA |
? |
|
11.8 |
12.9 |
16.6 |
13.7 |
15.9 |
|
14.9 |
|
Debt/EBITDA |
|
|
0.00 |
2.67 |
3.04 |
2.82 |
3.46 |
|
3.46 |
|
|
R&D/CAPEX, % |
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.00% |
0.71% |
0.54% |
0.61% |
0.63% |
|
0.62% |
|
| Cigna Corporation shareholders |
